Abstract:Background: Positive lymph node ratio (LNR) is associated with the prognosis of many cancers. However, its prognostic value in patients with hypopharyngeal squamous cell carcinoma (HSCC) is unclear due to the rarity of HSCC. This study aimed to investigate the prognostic value of LNR in HSCC using the Surveillance, Epidemiology, and End Results (SEER) database.Methods: Data spanning 2004 to 2015 of eligible HSCC patients were retrospectively retrieved from the SEER database. Clinicopathological data, including age at diagnosis, race, gender, marital status, primary tumor site, tumor size, tumor grade, Tumor-Lymph Node-Metastasis (TNM) stage, surgical type, postoperative adjuvant therapy (POAT) record, the number of lymph nodes (LNs) examined, the number of positive LNs, survival time, and death classification were collected and dichotomized through the receiver operating characteristic (ROC) curve. The LNR was defined as the ratio of positive LNs to the total number of LNs examined. The Kaplan-Meier method and Cox regression models were used to assess the association between LNR vs. cancer-specific survival (CSS) and overall survival (OS).Results: The 5-year CSS and OS rates of the 391 patients were 44% and 33.7%, respectively. The median LNR was 0.083 [interquartile range (IQR), 0.043-0.179], and the optimal cut-off value of LNR was 0.23. Kaplan-Meier curves showed that patients with LNR ≥0.23 had significantly shorter CSS and OS than LNR <0.23. In multivariable analysis, large tumor size [hazard ratio (HR): 1.012, P=0.016], N3 stage (HR: 2.113, P=0.040), M1 stage (HR: 2.458, P=0.041), with POAT (HR: 0.559, P=0.001), and LNR ≥0.23 (HR: 1.795, P=0.001) independently predicted CSS, while old age (HR: 1.019, P=0.009), large tumor size (HR: 1.012, P=0.006), M1 stage (HR: 3.422, P=0.001), with POAT (HR: 0.610, P=0.001), and LNR ≥0.23 (HR: 1.667, P=0.001) independently predicted OS. The subgroup analysis showed that patients with LNR ≥0.23 shared worse CSS and OS in either N2 or N3 subgroups than those with LNR <0.23. Furthermore, POAT provided an independent protective factor in the LNR ≥0.23 group, while it had no significant effect in the LNR <0.23 group.Conclusions: This study demonstrates a strong association between LNR and prognosis in patients with LNs metastatic HSCC. Further, it provides an alternative tool for providing supplemental information regarding prognosis.

The Prognostic Prediction Value of Positive Lymph Nodes Numbers for the Hypopharyngeal Squamous Cell Carcinoma

Number of Positive Lymph Nodes is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Prognostic Importance of Numbers of Retrieved Lymph Nodes and Positive Lymph Nodes for Ampulla of Vater Cancer (AVC) in 2347 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database.

Positive lymph node ratio predicts adverse prognosis for patients with lymph nodes metastatic hypopharyngeal squamous cell carcinoma after primary surgery

Incorporation Of The Number Of Positive Lymph Nodes Leads To Better Prognostic Discrimination Of Node-Positive Early Stage Cervical Cancer

The Number and Ratio of Positive Lymph Nodes Are Independent Prognostic Factors for Patients with Major Salivary Gland Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset.

Validation of the Prognostic Value in Various Lymph Node Staging Systems for Cervical Squamous Cell Carcinoma Following Radical Surgery: A Single‑center Analysis of 3,732 Patients

Number of positive lymph nodes and lymph node ratio predict recurrence and survival in hypopharyngeal cancer based on SEER database and validation of real-world data

Proposal Of The Optimal Numbers Of Examined And Positive Lymph Nodes To The 8th Edition Of American Joint Committee On Cancer (Ajcc) Staging For 758 Patients With Distal Cholangiocarcinoma

Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single-center analysis of 3,732 patients

Comprehensive Analysis of Prognostic Value of Lymph Node Staging Classifications in Patients with Head and Neck Squamous Cell Carcinoma after Cervical Lymph Node Dissection

The Positive Lymph Node Ratio Predicts Long-Term Survival in Patients with Operable Thoracic Esophageal Squamous Cell Carcinoma in China

Comparative Analysis of Methodologies for Predicting Overall Survival in Patients with Non‐small Cell Lung Cancer Based on the Number and Rate of Resected Positive Lymph Nodes: A Study Based on the SEER Database for 2010 Through 2019

The Prognostic Value of the Number of Negative Lymph Nodes Combined with Positive Lymph Nodes in Esophageal Cancer Patients: A Propensity-Matched Analysis

Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer

Prognostic Value of Preoperative Platelet-to-Lymphocyte Ratio and Platelet-Related Indexes in Advanced Hypopharyngeal Squamous Cell Carcinoma

The Value of Positive Lymph Nodes Ratio Combined with Negative Lymph Node Count in Prediction of Breast Cancer Survival.

Lymph node ratio as a survival predictor for head and neck squamous cell carcinoma with multiple adverse pathological features

The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988–2008)

Number of positive lymph nodes better predicts survival for oral cavity cancer

Prognostic Value of Log Odds of Positive Lymph Nodes in Node-Positive Lung Squamous Cell Carcinoma Patients after Surgery: a SEER Population-Based Study.